Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Nova S, et al
Ozempic and GLP-1 Drug Vision Loss Lawsuits New cases are now being filed against the manufacturers of weight loss GLP-1 drugs, including Ozempic, due to the development of a significant eye condition called NAION or non-arterial anterior ischemic optic neuropathy
Survey Findings Weight Loss Treatment Doesnt Stop at GLP-1s: Two-thirds (67%) of healthcare providers report increasing metformin prescriptions for patients who dont qualify for GLP-1s
You're gonna grandfather in peptides and give people accessibility to peptides, and that would be the Wild West
The timeframe for these changes varies depending on the specific drug's half-life and how long you have been taking it, but most effects begin to diminish within days to weeks after the last dose